Cargando…

Structural and Functional View of Polypharmacology

Protein domains mediate drug-protein interactions and this principle can guide the design of multi-target drugs i.e. polypharmacology. In this study, we associate multi-target drugs with CATH functional families through the overrepresentation of targets of those drugs in CATH functional families. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Moya-García, Aurelio, Adeyelu, Tolulope, Kruger, Felix A., Dawson, Natalie L., Lees, Jon G., Overington, John P., Orengo, Christine, Ranea, Juan A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579063/
https://www.ncbi.nlm.nih.gov/pubmed/28860623
http://dx.doi.org/10.1038/s41598-017-10012-x
_version_ 1783260631328096256
author Moya-García, Aurelio
Adeyelu, Tolulope
Kruger, Felix A.
Dawson, Natalie L.
Lees, Jon G.
Overington, John P.
Orengo, Christine
Ranea, Juan A. G.
author_facet Moya-García, Aurelio
Adeyelu, Tolulope
Kruger, Felix A.
Dawson, Natalie L.
Lees, Jon G.
Overington, John P.
Orengo, Christine
Ranea, Juan A. G.
author_sort Moya-García, Aurelio
collection PubMed
description Protein domains mediate drug-protein interactions and this principle can guide the design of multi-target drugs i.e. polypharmacology. In this study, we associate multi-target drugs with CATH functional families through the overrepresentation of targets of those drugs in CATH functional families. Thus, we identify CATH functional families that are currently enriched in drugs (druggable CATH functional families) and we use the network properties of these druggable protein families to analyse their association with drug side effects. Analysis of selected druggable CATH functional families, enriched in drug targets, show that relatives exhibit highly conserved drug binding sites. Furthermore, relatives within druggable CATH functional families occupy central positions in a human protein functional network, cluster together forming network neighbourhoods and are less likely to be within proteins associated with drug side effects. Our results demonstrate that CATH functional families can be used to identify drug-target interactions, opening a new research direction in target identification.
format Online
Article
Text
id pubmed-5579063
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55790632017-09-06 Structural and Functional View of Polypharmacology Moya-García, Aurelio Adeyelu, Tolulope Kruger, Felix A. Dawson, Natalie L. Lees, Jon G. Overington, John P. Orengo, Christine Ranea, Juan A. G. Sci Rep Article Protein domains mediate drug-protein interactions and this principle can guide the design of multi-target drugs i.e. polypharmacology. In this study, we associate multi-target drugs with CATH functional families through the overrepresentation of targets of those drugs in CATH functional families. Thus, we identify CATH functional families that are currently enriched in drugs (druggable CATH functional families) and we use the network properties of these druggable protein families to analyse their association with drug side effects. Analysis of selected druggable CATH functional families, enriched in drug targets, show that relatives exhibit highly conserved drug binding sites. Furthermore, relatives within druggable CATH functional families occupy central positions in a human protein functional network, cluster together forming network neighbourhoods and are less likely to be within proteins associated with drug side effects. Our results demonstrate that CATH functional families can be used to identify drug-target interactions, opening a new research direction in target identification. Nature Publishing Group UK 2017-08-31 /pmc/articles/PMC5579063/ /pubmed/28860623 http://dx.doi.org/10.1038/s41598-017-10012-x Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Moya-García, Aurelio
Adeyelu, Tolulope
Kruger, Felix A.
Dawson, Natalie L.
Lees, Jon G.
Overington, John P.
Orengo, Christine
Ranea, Juan A. G.
Structural and Functional View of Polypharmacology
title Structural and Functional View of Polypharmacology
title_full Structural and Functional View of Polypharmacology
title_fullStr Structural and Functional View of Polypharmacology
title_full_unstemmed Structural and Functional View of Polypharmacology
title_short Structural and Functional View of Polypharmacology
title_sort structural and functional view of polypharmacology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579063/
https://www.ncbi.nlm.nih.gov/pubmed/28860623
http://dx.doi.org/10.1038/s41598-017-10012-x
work_keys_str_mv AT moyagarciaaurelio structuralandfunctionalviewofpolypharmacology
AT adeyelutolulope structuralandfunctionalviewofpolypharmacology
AT krugerfelixa structuralandfunctionalviewofpolypharmacology
AT dawsonnataliel structuralandfunctionalviewofpolypharmacology
AT leesjong structuralandfunctionalviewofpolypharmacology
AT overingtonjohnp structuralandfunctionalviewofpolypharmacology
AT orengochristine structuralandfunctionalviewofpolypharmacology
AT raneajuanag structuralandfunctionalviewofpolypharmacology